Duolingo Stock News

PITTSBURGH, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Duolingo, Inc. (NASDAQ: DUOL) announced results for the third quarter ended September 30, 2026 in a shareholder letter that is posted on its Investor Relations website at investors.duolingo.com. "We had a great Q3, with DAU growth accelerating to 29% year over year, and all of our key financial metrics coming in ahead of expectations," said Luis von...

Popular language-learning app Duolingo is facing a class-action lawsuit accusing its executives of keeping investors in the dark about monetization and AI efforts that drove away customers.

NEW YORK, Oct. 19, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Duolingo, Inc. (“Duolingo” or the “Company”) (NASDAQ: DUOL) on behalf of investors that purchased or otherwise acquired Duolingo Class A common stock between May 2, 2025 and February 26, 2026 (the “Class Period”). CLICK HERE TO JOIN THE CASE If you are an investor...

PITTSBURGH, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Duolingo, Inc. (Nasdaq: DUOL) today announced that Luis von Ahn, Co-Founder and Chief Executive Officer, will participate in a fireside chat at the Citi 2026 Global TMT Conference on September 9, 2026 at 10:10 a.m.

Duolingo stock has crawled back in the past few months, moving to its highest point since January this year. DUOL soared to $162, up by 77% from its lowest level this year.

Duolingo stock rose more than 5% on Tuesday after Evercore ISI upgraded the language-learning company to Outperform from In Line and raised its price target to $210 from $105. The new target implies nearly 42% upside from Monday's close.

Duolingo DUOL stock climbed 6.6% on Tuesday despite a broader market decline, after DA Davidson upgraded the language-learning company's shares to Buy and raised its price target. The move comes as investors weigh concerns about slowing user growth and monetization against continued improvements in the company's core product and recent strategic developments.